153 related articles for article (PubMed ID: 37782418)
1. Hysteroscopy-assisted suction curettage for early pregnancy loss: does it reduce retained products of conception and postoperative intrauterine adhesions?
Moore O; Tzur T; Vaknin Z; Rabbi ML; Smorgick N
Arch Gynecol Obstet; 2024 Jan; 309(1):205-210. PubMed ID: 37782418
[TBL] [Abstract][Full Text] [Related]
2. Postpartum retained products of conception: Is it possible to avoid postpartum curettage?
Nir A; Mor M; Yekutiel M; Eisenberg N; Smorgick N
Int J Gynaecol Obstet; 2022 Feb; 156(2):231-235. PubMed ID: 33811338
[TBL] [Abstract][Full Text] [Related]
3. Intrauterine adhesions after hysteroscopic treatment for retained products of conception: what are the risk factors?
Barel O; Krakov A; Pansky M; Vaknin Z; Halperin R; Smorgick N
Fertil Steril; 2015 Mar; 103(3):775-9. PubMed ID: 25527235
[TBL] [Abstract][Full Text] [Related]
4. Hysteroscopic morcellation vs. curettage for removal of retained products of conception: a multicenter randomized controlled trial.
Wagenaar LP; Hamerlynck TW; Radder CM; Peters LW; Weyers S; Schoot BC; van Vliet HA
Fertil Steril; 2023 Dec; 120(6):1243-1251. PubMed ID: 37657600
[TBL] [Abstract][Full Text] [Related]
5. Hysteroscopic management of retained products of conception: meta-analysis and literature review.
Smorgick N; Barel O; Fuchs N; Ben-Ami I; Pansky M; Vaknin Z
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():19-22. PubMed ID: 24332096
[TBL] [Abstract][Full Text] [Related]
6. Hysteroscopic removal of retained products of conception following first trimester medical abortion.
Smorgick N; Levinsohn-Tavor O; Ben-Ami I; Maymon R; Pansky M; Vaknin Z
Gynecol Minim Invasive Ther; 2017; 6(4):183-185. PubMed ID: 30254910
[TBL] [Abstract][Full Text] [Related]
7. Increased Fetal Chromosome Detection with the Use of Operative Hysteroscopy During Evacuation of Products of Conception for Diagnosed Miscarriage.
Cholkeri-Singh A; Zamfirova I; Miller CE
J Minim Invasive Gynecol; 2020 Jan; 27(1):160-165. PubMed ID: 30926368
[TBL] [Abstract][Full Text] [Related]
8. Hysteroscopic Removal of Retained Products of Conception Implanted Over a Focal Area of Adenomyosis: A Case Report.
Alonso L; Nieto L; Carugno J
J Minim Invasive Gynecol; 2018; 25(3):382-383. PubMed ID: 28939480
[TBL] [Abstract][Full Text] [Related]
9. Two-step hysteroscopy for management of morbidly adherent retained products of conception.
Smorgick N; Rabinovitch I; Levinsohn-Tavor O; Maymon R; Vaknin Z; Pansky M
Arch Gynecol Obstet; 2019 Sep; 300(3):669-674. PubMed ID: 31321494
[TBL] [Abstract][Full Text] [Related]
10. Hysteroscopic management of residual trophoblastic tissue is superior to ultrasound-guided curettage.
Rein DT; Schmidt T; Hess AP; Volkmer A; Schöndorf T; Breidenbach M
J Minim Invasive Gynecol; 2011; 18(6):774-8. PubMed ID: 22024264
[TBL] [Abstract][Full Text] [Related]
11. Is Hysteroscopy the Best Surgical Approach for Removal of Retained Products of Conception Following Surgical Termination of Pregnancy?
Smorgick N; Kostin S; Tzur T; Levinsohn-Tavor O; Maymon R; Vaknin Z
J Obstet Gynaecol Can; 2020 Aug; 42(8):953-956. PubMed ID: 32386964
[TBL] [Abstract][Full Text] [Related]
12. Utility of Office Hysteroscopy in Diagnosing Retained Products of Conception Following Early Pregnancy Loss After In Vitro Fertilization.
George JS; Naert MN; Lanes A; Yin S; Bharadwa S; Ginsburg ES; Srouji SS
Obstet Gynecol; 2023 Nov; 142(5):1019-1027. PubMed ID: 37769303
[TBL] [Abstract][Full Text] [Related]
13. Intercoat (Oxiplex/AP gel) for preventing intrauterine adhesions after operative hysteroscopy for suspected retained products of conception: double-blind, prospective, randomized pilot study.
Fuchs N; Smorgick N; Ben Ami I; Vaknin Z; Tovbin Y; Halperin R; Pansky M
J Minim Invasive Gynecol; 2014; 21(1):126-30. PubMed ID: 23954387
[TBL] [Abstract][Full Text] [Related]
14. Incidence of post-abortion intra-uterine adhesions evaluated by hysteroscopy--a prospective study.
Friedler S; Margalioth EJ; Kafka I; Yaffe H
Hum Reprod; 1993 Mar; 8(3):442-4. PubMed ID: 8473464
[TBL] [Abstract][Full Text] [Related]
15. Office hysteroscopy in removing retained products of conception - a highly successful approach with minimal complications.
Jakopič Maček K; Blaganje M; Kenda Šuster N; Drusany Starič K; Kobal B
J Obstet Gynaecol; 2020 Nov; 40(8):1122-1126. PubMed ID: 31793362
[TBL] [Abstract][Full Text] [Related]
16. Live birth rate and obstetric complications following the hysteroscopic management of intrauterine adhesions including Asherman syndrome.
Deans R; Vancaillie T; Ledger W; Liu J; Abbott JA
Hum Reprod; 2018 Oct; 33(10):1847-1853. PubMed ID: 30239778
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of uterine synechia after abortion evacuation curettage.
Salzani A; Yela DA; Gabiatti JR; Bedone AJ; Monteiro IM
Sao Paulo Med J; 2007 Sep; 125(5):261-4. PubMed ID: 18094891
[TBL] [Abstract][Full Text] [Related]
18. Restoring Fertility of Patients with Severe Asherman's Syndrome in the Office Setting: A Step-by-Step Recipe for Success.
Di Spiezio-Sardo A; De Angelis MC; Dimitrios K; Manzi A; Zizolfi B; Carugno J; Isaacson K
J Minim Invasive Gynecol; 2023 May; 30(5):355-356. PubMed ID: 36764649
[TBL] [Abstract][Full Text] [Related]
19. Retained products of conception: What is the risk for recurrence on subsequent pregnancies?
Smorgick N; Mittler A; Ben-Ami I; Maymon R; Vaknin Z; Pansky M
Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():1-5. PubMed ID: 29525517
[TBL] [Abstract][Full Text] [Related]
20. A novel method for office aspiration curettage in cases of retained products of conception: A randomized controlled trial.
Pomeranz M; Goren Gepstein N; Ovadia M; Klein Z; Daykan Y; Schonman R; Arbib N
Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2076-2081. PubMed ID: 34467531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
